1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Program terminated by USAID in September 2023.
The United States Agency for International Development (USAID) is seeking applications for a cooperative agreement from qualified entities to implement the Discovery & Exploration of Emerging Pathogens – Viral Zoonoses (DEEP VZN) program. Eligibility for this award is not restricted.Deadline for Questions: May 20, 2021; 1:00 p.m., Washington, DC TimeClosing Date: June 17, 2021Closing Time: 1:00 p.m., Washington, DC Time
Funding Opportunity Number: 7200AA21RFA00005. Assistance Listing: 98.001. Funding Instrument: CA. Category: HL. Award Amount: Up to $125M per award.
Get alerted about grants like this
Get emailed when new opportunities from “Agency for International Development” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility. Cost sharing or matching funds are required. Confirm the full requirements in the official notice before applying.
The current listing shows up to $125M per award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 17, 2021, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Yes — Discovery & Exploration of Emerging Pathogens – Viral Zoonoses (DEEP VZN) is offered by Agency for International Development and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Call for Proposals to Support Small-Scale Development Projects (Slovakia Small Grants 2026) is sponsored by Slovak Agency for International Development Cooperation. This program supports flexible and locally driven development initiatives that respond directly to the needs of communities in Tanzania across sectors such as quality education, healthcare and social care, good governance, sustainable agriculture, environmental sustainability, a…
USAID Act to End NTDs | East program is sponsored by U.S. Agency for International Development (USAID). This program supports countries in Africa, Asia, and Latin America to achieve targets for controlling and eliminating neglected tropical diseases including schistosomiasis. It focuses on delivering treatments, monitoring progress, and ensuring health systems can sustain NTD services. The program aims to advance toward World Health Organization global NTD goals, including a 90% reduction in people needing interventions by 2030.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.